Axogen Reports New Employee Incentive Grant Under NASDAQ Listing Rule 5635(C)(4)

ALACHUA, Fla. and TAMPA, Fla., Sept. 3, 2024 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and commercializing innovative surgical solutions for peripheral nerve injury, today announced that on September 3, 2024, it granted an equity award to a new non-executive employee under the terms of Axogen Inc.'s Inducement Equity Incentive Plan. The award was approved by the Compensation Committee of Axogen's Board of Directors in accordance with NASDAQ Listing Rule 5635(c)(4) and served as a material incentive for the employee's acceptance of employment with Axogen.

The award consists of restricted stock units (“RSUs”) representing 10,000 shares of the Company’s common stock. The RSUs are subject to a 4-year vesting period, with 50% of the total shares granted vesting after the second year and 25% of the total shares granted vesting each year for the following two years.